FMS Stock Analysis: Buy, Sell, or Hold?
FMS - Fresenius Medical Care AG
$22.70
0.18 (0.80%)
▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 24, 2026
22d
Get Alerted When FMS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: FMS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: FMS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$28.58
Based on 5.2% avg growth
INTRINSIC VALUE TODAY
$17.75
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FMS is currently trading at $22.70, which is considered fair relative to its 30-day fair value range of $21.91 to $23.70. The stock's valuation (Forward PE: 7.8) is in line with its historical norms (7.6). At these levels, the market is pricing in 0.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, FMS is in a strong downtrend. The price is approaching resistance at $22.75. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: FMS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.52 (+25.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, FMS is in a strong downtrend. The price is approaching resistance at $22.75. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: FMS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $28.52 (+25.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$21.91 -
$23.70
Company Quality Score
57/100
(HOLD)
Options IV Signal
54th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
81.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 54th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 25.6% below Wall St target ($28.52)
- NEUTRAL: Market pricing in 0.7% annual earnings growth - fairly valued
Fair Price Analysis
30-Day Fair Range
$21.91 -
$23.70
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$1.72
(7.6%)
Support & Resistance Levels
Support Level
$20.95
Resistance Level
$22.75
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
7.76
Wall Street Target
$28.52
(+25.6%)
Revenue Growth (YoY)
2.6%
Earnings Growth (YoY)
29.5%
Profit Margin
3.7%
Valuation Premium vs History
+0.7% premium
PE vs Historical
7.8 vs 7.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.7%
(market-implied from PE analysis)
1-Year Target
$22.86
(+1%)
2-Year Target
$23.02
(+1%)
3-Year Target
$23.18
(+2%)
3-Yr Target (if PE normalizes)
(PE: 8→8)
PE COMPRESSION
$22.71
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 6.3%)
$78.41
(+245%)
Base:
(SPY PE: 7.8, Growth: 6.3%)
$27.27
(+20%)
Bear:
(PE: 6.6, Growth: 6.3%)
$23.18
(+2%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (15x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 15.10 | Current EPS (TTM): $1.47
Bull Case
$48.59
(+114%)
Analyst growth 99.1%, PE expands to 16.6
Base Case
$44.17
(+95%)
Market implied 99.1%, PE stable at 15.1
Bear Case
$15.09
(-34%)
Severe decline -20.0%, PE contracts to 12.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: February 01, 2026 3:37 PM ET
Data refreshes hourly during market hours. Next update: 4:37 PM
Data refreshes hourly during market hours. Next update: 4:37 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FMS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$529 | 63 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$238 | 54 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$140 | 54 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$17 | 52 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$28 | 62 BUY |
